Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $162.0M | $157.2M | $165.5M | $168.5M | $163.3M | $157.4M | $170.9M | $227.4M | $347.2M | $340.1M | $406.2M | $467.2M | $500.3M | $576.5M | $555.6M | $552.2M | $547.5M | $620.6M | $625.3M | $624.4M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Prestige Consumer Healthcare Inc.'s last 12-month Gross Profit is $601.8M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Prestige Consumer Healthcare Inc.'s Gross Profit growth was (2.8%). The average annual Gross Profit growth rates for Prestige Consumer Healthcare Inc. have been 3.2% over the past three years, 1.9% over the past five years.
Over the last year, Prestige Consumer Healthcare Inc.'s Gross Profit growth was (2.8%), which is lower than industry growth of 0.1%. It indicates that Prestige Consumer Healthcare Inc.'s Gross Profit growth is Bad.